Flesh colored, painful nodular plaques on the vertex of the scalp which frequently discharge a seropurulent material. Patient reports a loss of hair in the affected area and states the condition ...

While IL-23 inhibitors, which include guselkumab, tildrakizumab, and risankizumab, are currently FDA-approved solely for the treatment of psoriasis, several other inflammatory skin conditions have ...